 |
|
Former Addicts Face Barriers to Treatment for HCV
Joan Stephenson, PhD
JAMA. 2001;285:1003-1005.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Most injection drug users, including those who succeed in kicking the habit, are left with a worrisome legacy: infection with hepatitis C virus (HCV). But for a variety of reasons, some former addicts who develop HCV-related liver disease—notably those receiving methadone maintenance therapy (MMT)—are confronted with barriers to getting much-needed treatment for their illness, barriers that sometimes force them to choose between dying of liver disease and risking relapse and a return to abusing drugs.
The problem is not a trivial one. More than any other group of individuals in the United States, injection drug users are likely to acquire the infection. According to the National Center for Infectious Diseases, half or more of all HCV infections are associated with illegal drug use and injection drug users typically become infected with stunning swiftness.
Despite the HCV burden in this group, physicians say that patients receiving MMT—including individuals . . . [Full Text of this Article]
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Response by Butt, Paterson, and McGuinness
West J Nurs Res 2008;30:230-233.
The Effect of Multiple Doses of Peginterferon alfa-2b on the Steady-State Pharmacokinetics of Methadone in Patients With Chronic Hepatitis C Undergoing Methadone Maintenance Therapy
Gupta et al.
J Clin Pharmacol 2007;47:604-612.
ABSTRACT
| FULL TEXT
Health Values of Patients With Chronic Hepatitis C Infection
Sherman et al.
Arch Intern Med 2004;164:2377-2382.
ABSTRACT
| FULL TEXT
Treating Opioid Dependence: Growing Implications for Primary Care
Krantz and Mehler
Arch Intern Med 2004;164:277-288.
ABSTRACT
| FULL TEXT
Treatment of Chronic Hepatitis C in Active Drug Users
Davis and Rodrigue
NEJM 2001;345:215-217.
FULL TEXT
|
